Clinical impact of walking capacity on the risk of disability and hospitalizations among elderly patients with advanced lung cancer.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 14 07 2020
accepted: 15 12 2020
pubmed: 5 1 2021
medline: 12 6 2021
entrez: 4 1 2021
Statut: ppublish

Résumé

Little is known about the impact of decreased walking capacity on clinical outcomes in elderly patients with cancer. This prospective observational study aimed to investigate the impact of walking capacity on the risk of disability and hospitalization in elderly patients with advanced lung cancer. This study prospectively enrolled 60 patients aged ≥ 70 years with advanced non-small-cell lung cancer (NSCLC) scheduled to receive first-line chemotherapy or radical radiotherapy between January 2013 and December 2014 (trial registration number: UMIN000009768). Patients were classified into the mobile or less mobile group based on the median incremental shuttle walking distance (ISWD) before initial treatment. Assessments included the Barthel index, disability-free survival time, mean cumulative lengths of hospital stay, and inpatient medical costs. The median ISWD was 290 m (interquartile range, 245-357.5 m). The mobile group (ISWD ≥ 290 m) had a longer disability-free survival time than the less mobile group (ISWD < 290 m, 24.6 months vs. 8.4 months, p < 0.05). During the first year from study entry, the mobile group had shorter cumulative lengths of hospital stay (41.3 vs. 72.9 days/person, p < 0.05) and lower inpatient medical costs (¥1.9 vs. ¥2.9 million/person, p < 0.05) than the less mobile group. Elderly NSCLC patients with adequate walking capacity showed lower risks of disability, shorter hospitalizations, and lower inpatient medical costs than patients with reduced walking capacity. Further prospective research is needed to validate these findings. The trial was registered with the University Hospital Medical Information Network as trial number UMIN000009768 on January 13, 2013. UMIN000009768.

Identifiants

pubmed: 33392773
doi: 10.1007/s00520-020-05953-5
pii: 10.1007/s00520-020-05953-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3961-3970

Références

Takayuki N, Keiko T, Junji U, Yoshiko K, Nobuyo T, Tadaaki Y, Koichi T (2018) Advanced non-small-cell lung cancer in elderly patients: patient features and therapeutic management. Biomed Res Int 30:8202971–8202978. https://doi.org/10.1155/2018/8202971
doi: 10.1155/2018/8202971
Banegas MP, Yabroff KR, O’Keeffe-Rosetti MC, Ritzwoller DP, Fishman PA, Salloum RG, Lafata JE, Hornbrook MC (2018) Medical care costs associated with cancer in integrated delivery systems. J Natl Compr Canc Netw 16:402–410. https://doi.org/10.6004/jnccn.2017.7065
doi: 10.6004/jnccn.2017.7065 pubmed: 29632060
Yin X, Xu Y, Man X, Liu L, Jiang Y, Zhao L, Cheng W (2019) Direct costs of both inpatient and outpatient care for all type cancers: the evidence from Beijing, China. Cancer Med 8:3250–3260. https://doi.org/10.1002/cam4.2184
doi: 10.1002/cam4.2184 pubmed: 31062522 pmcid: 6558587
Ministry of Health Law (2019) Estimates of medical care expenditure, summary for 2017. https://www.mhlw.go.jp/toukei/saikin/hw/k-iryohi/17/index.html . Accessed June 2, 2020
Luengo-Fernandez R, Leal J, Gray A, Sullivan R (2013) Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 14:1165–1174. https://doi.org/10.1016/S1470-2045(13)70442-X
doi: 10.1016/S1470-2045(13)70442-X pubmed: 24131614
Yi YS, Ban WH, Sohng KY (2018) Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer. BMC Cancer 18:1053. https://doi.org/10.1186/s12885-018-4976-3
doi: 10.1186/s12885-018-4976-3 pubmed: 30373585 pmcid: 6206922
Kimura M, Naito T, Kenmotsu H, Taira T, Wakuda K, Oyakawa T, Hisamatsu Y, Tokito T, Imai H, Akamatsu H, Ono A, Kaira K, Murakami H, Endo M, Mori K, Takahashi T, Yamamoto N (2015) Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer. Support Care Cancer 23:1699–1708. https://doi.org/10.1007/s00520-014-2534-3
doi: 10.1007/s00520-014-2534-3 pubmed: 25430482
Granger CL, Denehy L, McDonald CF, Irving L, Clark RA (2014) Physical activity measured using global positioning system tracking in non-small cell lung cancer: an observational study. Integr Cancer Ther 13:482–492. https://doi.org/10.1177/1534735414542484
doi: 10.1177/1534735414542484 pubmed: 25006040
Leach CR, Bellizzi KV, Hurria A, Reeve BB (2016) Is it my cancer or am I just getting older?: impact of cancer on age-related health conditions of older cancer survivors. Cancer 122:1946–1953. https://doi.org/10.1002/cncr.29914
doi: 10.1002/cncr.29914 pubmed: 27159822
Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version. Accessed at https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq on November 3, 2020
Naito T, Okayama T, Aoyama T, Ohashi T, Masuda Y, Kimura M, Shiozaki H, Murakami H, Kenmotsu H, Taira T, Ono A, Wakuda K, Imai H, Oyakawa T, Ishii T, Omori S, Nakashima K, Endo M, Omae K, Mori K, Yamamoto N, Tanuma A, Takahashi T (2017) Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study. BMC Cancer 17:800. https://doi.org/10.1186/s12885-017-3795-2
doi: 10.1186/s12885-017-3795-2 pubmed: 29183277 pmcid: 5706408
Naito T, Okayama T, Aoyama T, Ohashi T, Masuda Y, Kimura M, Shiozaki H, Murakami H, Kenmotsu H, Taira T, Ono A, Wakuda K, Imai H, Oyakawa T, Ishii T, Omori S, Nakashima K, Endo M, Omae K, Mori K, Yamamoto N, Tanuma A, Takahashi T (2017) Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer. BMC Cancer 17:571. https://doi.org/10.1186/s12885-017-3562-4
doi: 10.1186/s12885-017-3562-4 pubmed: 28841858 pmcid: 5574084
Jones LW, Hornsby WE, Goetzinger A, Forbes LM, Sherrard EL, Quist M, Lane AT, West M, Eves ND, Gradison M, Coan A, Herndon JE, Abernethy AP (2012) Prognostic significance of functional capacity and exercise behavior in patients with metastatic non-small cell lung cancer. Lung Cancer 76:248–252. https://doi.org/10.1016/j.lungcan.2011.10.009
doi: 10.1016/j.lungcan.2011.10.009 pubmed: 22112290
Kasymjanova G, Correa JA, Kreisman H, Dajczman E, Pepe C, Dobson S, Lajeunesse L, Sharma R, Small D (2009) Prognostic value of the six-minute walk in advanced non-small cell lung cancer. J Thorac Oncol 4:602–607. https://doi.org/10.1097/JTO.0b013e31819e77e8
doi: 10.1097/JTO.0b013e31819e77e8 pubmed: 19276833
Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, Lee AL, Camillo CA, Troosters T, Spruit MA, Carlin BW, Wanger J, Pepin V, Saey D, Pitta F, Kaminsky DA, McCormack MC, MacIntyre N, Culver BH, Sciurba FC, Revill SM, Delafosse V, Holland AE (2014) An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 44:1447–1478. https://doi.org/10.1183/09031936.00150414
doi: 10.1183/09031936.00150414 pubmed: 25359356
Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE (1992) Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 47:1019–1024. https://doi.org/10.1136/thx.47.12.1019
doi: 10.1136/thx.47.12.1019 pubmed: 1494764 pmcid: 1021093
Guigoz Y, Vellas B, Garry PJ (1996) Assessing the nutritional status of the elderly: the mini nutritional assessment as part of the geriatric evaluation. Nutr Rev 54:S59–S65. https://doi.org/10.1111/j.1753-4887.1996.tb03793.x
doi: 10.1111/j.1753-4887.1996.tb03793.x pubmed: 8919685
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489–495. https://doi.org/10.1016/S1470-2045(10)70218-7
doi: 10.1016/S1470-2045(10)70218-7 pubmed: 21296615
Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB, Baracos VE (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539–1547. https://doi.org/10.1200/JCO.2012.45.2722
doi: 10.1200/JCO.2012.45.2722 pubmed: 23530101
Mourtzakis M, Prado CMM, Lieffers J, Reiman T, McCargar LJ, Baracos VE (2008) A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33:997–1006. https://doi.org/10.1139/H08-075
doi: 10.1139/H08-075 pubmed: 18923576
Nelson W (1995) Confidence limits for recurrence data—applied to cost or number of product repairs. Technometrics 37:147–157. https://doi.org/10.1080/00401706.1995.10484299
doi: 10.1080/00401706.1995.10484299
Smedira NG, Hoercher KJ, Lima B, Mountis MM, Starling R, Thuita L, Schmuhl D, Blackstone E (2013) Unplanned hospital readmissions after HeartMate II implantation: frequency, risk factors, and impact on resource use and survival. JACC Heart Fail 1:31–39. https://doi.org/10.1016/j.jchf.2012.11.001
doi: 10.1016/j.jchf.2012.11.001 pubmed: 24621797
Ishii S, Tanaka T, Shibasaki K, Ouchi Y, Kikutani T, Higashiguchi T, Obuchi SP, Ishikawa-Takata K, Hirano H, Kawai H, Tsuji T, Iijima K (2014) Development of a simple screening test for sarcopenia in older adults. Geriatr Gerontol Int 14(Suppl 1):93–101. https://doi.org/10.1111/ggi.12197
doi: 10.1111/ggi.12197 pubmed: 24450566
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, MA MB, Cardiovascular Health Study Collaborative Research Group (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156. https://doi.org/10.1093/gerona/56.3.m146
doi: 10.1093/gerona/56.3.m146 pubmed: 11253156
Sherrington C, Tiedemann A, Fairhall N, Close JCT, Lord SR (2011) Exercise to prevent falls in older adults: an updated meta-analysis and best practice recommendations. N S W Public Health Bull 22:78–83. https://doi.org/10.1071/NB10056
doi: 10.1071/NB10056 pubmed: 21632004
Chen S, Qin J, Li Y, Wei Y, Long B, Cai J, Tang J, Xu X, Yu G, Zhang Z (2018) Disability and its influencing factors among the elderly in a county, Guangxi Province, China. Int J Environ Res Public Health 15:1967. https://doi.org/10.3390/ijerph15091967
doi: 10.3390/ijerph15091967 pmcid: 6163965
García-Nogueras I, Aranda-Reneo I, Peña-Longobardo LM, Oliva-Moreno J, Abizanda P (2017) Use of health resources and healthcare costs associated with frailty: the FRADEA study. J Nutr Health Aging 21:207–214. https://doi.org/10.1007/s12603-016-0727-9
doi: 10.1007/s12603-016-0727-9 pubmed: 28112778
Arnau A, Espaulella J, Méndez T, Serrarols M, Canudas J, Formiga F, Ferrer M (2016) Lower limb function and 10-year survival in population aged 75 years and older. Family Pract 33:10–16. https://doi.org/10.1093/fampra/cmv088
doi: 10.1093/fampra/cmv088
Morishita T, Sato M, Kume H, Sakuma M, Arai H, Katayama T, Katoh S, Sairyo K, Takeda E (2018) Skeletal muscle mass of old Japanese women suffering from walking difficulty in nursing home. J Med Invest 65:122–130. https://doi.org/10.2152/jmi.65.122
doi: 10.2152/jmi.65.122 pubmed: 29593181
Misu S, Asai T, Doi T, Sawa R, Ueda Y, Saito T, Nakamura R, Murata S, Sugimoto T, Yamada M, Ono R (2017) Association between gait abnormality and malnutrition in a community-dwelling elderly population. Geriatr Gerontol Int 17:1155–1160. https://doi.org/10.1111/ggi.12839
doi: 10.1111/ggi.12839 pubmed: 27426987
Huang MH, Blackwood J, Godoshian M, Pfalzer L (2018) Factors associated with self-reported falls, balance or walking difficulty in older survivors of breast, colorectal, lung, or prostate cancer: results from surveillance, epidemiology, and end results-medicare health outcomes survey linkage. PLoS One 13:e0208573. https://doi.org/10.1371/journal.pone.0208573
doi: 10.1371/journal.pone.0208573 pubmed: 30566443 pmcid: 6300321
Wallengren O, Lundholm K, Bosaeus I (2013) Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients. Support Care Cancer 21:1569–1577. https://doi.org/10.1007/s00520-012-1697-z
doi: 10.1007/s00520-012-1697-z pubmed: 23314651
Morikawa A, Naito T, Sugiyama M, Okayama T, Aoyama T, Tanuma A, Omae K, Takahashi T (2018) Impact of cancer cachexia on hospitalization-associated physical inactivity in elderly patients with advanced non-small-cell lung cancer. Asia Pac J Oncol Nurs 5:377–382. https://doi.org/10.4103/apjon.apjon_20_18
doi: 10.4103/apjon.apjon_20_18 pubmed: 30271819 pmcid: 6103202
Miyawaki A, Naito T, Nakashima K, Miyawaki T, Mamesaya N, Kawamura T, Kobayashi H, Omori S, Wakuda K, Ono A, Kenmotsu H, Murakami H, Mori K, Takahashi T (2020) Management of anorexia prevents skeletal muscle wasting during cisplatin-based chemotherapy for thoracic malignancies. JCSM Clinical Reports 5:8–15. https://doi.org/10.1002/crt2.8
doi: 10.1002/crt2.8
Fong JH, Feng J (2018) Comparing the loss of functional independence of older adults in the U.S. and China. Arch Gerontol Geriatr 74:123–127. https://doi.org/10.1016/j.archger.2017.10.020
doi: 10.1016/j.archger.2017.10.020 pubmed: 29096226
Dunlop DD, Hughes SL, Manheim LM (1997) Disability in activities of daily living: patterns of change and a hierarchy of disability. Am J Public Health 87:378–383. https://doi.org/10.2105/ajph.87.3.378
doi: 10.2105/ajph.87.3.378 pubmed: 9096537 pmcid: 1381008
Shulman MA, Cuthbertson BH, Wijeysundera DN, Pearse RN, Thompson B, Torres E, Ambosta A, Wallace S, Farrington C, Myles PS, Measurement of Exercise Tolerance for Surgery Study Investigators (2019) Using the 6-minute walk test to predict disability-free survival after major surgery. Br J Anaesth 122:111–119. https://doi.org/10.1016/j.bja.2018.08.016
doi: 10.1016/j.bja.2018.08.016 pubmed: 30579389
Cheng Y, Goodin A, Pahor M, Manini T, Brown JD (2020) Healthcare utilization and physical functioning in older adults in the United States. J Am Geriatr Soc 38:266–271. https://doi.org/10.1111/jgs.16260
doi: 10.1111/jgs.16260
Fried TR, Bradley EH, Williams CS, Tinetti ME (2001) Functional disability and health care expenditures for older persons. Arch Intern Med 161:2602–2607. https://doi.org/10.1001/archinte.161.21.2602
doi: 10.1001/archinte.161.21.2602 pubmed: 11718592
Lin MH, Chen SR, Liao MN, Chen YC, Chang WY (2017) Factors and medical costs associated with fall events in hospitalized patients. Hu Li Za Zhi 64:44–52. https://doi.org/10.6224/JN.000053
doi: 10.6224/JN.000053 pubmed: 28762224
Leal J, Gray AM, Prieto-Alhambra D, Arden NK, Cooper C, Javaid MK, Judge A, REFReSH study group (2016) Impact of hip fracture on hospital care costs: a population-based study. Osteoporos Int 27:549–558. https://doi.org/10.1007/s00198-015-3277-9
doi: 10.1007/s00198-015-3277-9 pubmed: 26286626
Park H, Adeyemi AO, Rascati KL (2015) Direct medical costs and utilization of health care services to treat pneumonia in the United States: an analysis of the 2007-2011 Medical Expenditure Panel Survey. Clin Ther 37:1466–1476.e1. https://doi.org/10.1016/j.clinthera.2015.04.013
doi: 10.1016/j.clinthera.2015.04.013 pubmed: 26001310
Wildes TM, Dua P, Fowler SA, Miller JP, Carpenter CR, Avidan MS, Stark S (2015) Systematic review of falls in older adults with cancer. J Geriatr Oncol 6:70–83. https://doi.org/10.1016/j.jgo.2014.10.003
doi: 10.1016/j.jgo.2014.10.003 pubmed: 25454770
Berggren M, Stenvall M, Englund U, Olofsson B, Gustafson Y (2016) Co-morbidities, complications and causes of death among people with femoral neck fracture-a three-year follow-up study. BMC Geriatr 16:120. https://doi.org/10.1186/s12877-016-0291-5
doi: 10.1186/s12877-016-0291-5 pubmed: 27260196 pmcid: 4893237
Naito T, Mitsunaga S, Miura S, Tatematsu N, Inano T, Mouri T, Tsuji T, Higashiguchi T, Inui A, Okayama T, Yamaguchi T, Morikawa A, Mori N, Takahashi T, Strasser F, Omae K, Mori K, Takayama K (2019) Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer. J Cachexia Sarcopenia Muscle 10:73–83. https://doi.org/10.1002/jcsm.12351
doi: 10.1002/jcsm.12351 pubmed: 30334618
Mouri T, Naito T, Morikawa A, Tatematsu N, Miura S, Okayama T, Omae K, Takayama K (2018) Promotion of behavioral change and the impact on quality of life in elderly patients with advanced cancer: a physical activity of the multimodal nutrition and exercise treatment for advanced cancer program. Asia Pac J Oncol Nurs 5:383–390. https://doi.org/10.4103/apjon.apjon_21_18
doi: 10.4103/apjon.apjon_21_18 pubmed: 30271820 pmcid: 6103203
Miura S, Naito T, Mitsunaga S, Omae K, Mori K, Inano T, Yamaguchi T, Tatematsu N, Okayama T, Morikawa A, Mouri T, Tanaka H, Kimura M, Imai H, Mizukami T, Imoto A, Kondoh C, Shiotsu S, Okuyama H, Ueno M, Takahashi T, Tsuji T, Aragane H, Inui A, Higashiguchi T, Takayama K (2019) A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small-cell lung or pancreatic cancer: the NEXTAC-TWO study protocol. BMC Cancer 19:528–528. https://doi.org/10.1186/s12885-019-5762-6
doi: 10.1186/s12885-019-5762-6 pubmed: 31151425 pmcid: 6544995

Auteurs

Taro Okayama (T)

Division of Rehabilitation Medicine, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Tateaki Naito (T)

Division of Thoracic Oncology, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan. t.naito@scchr.jp.

Yusuke Yonenaga (Y)

Division of Rehabilitation Medicine, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Takuya Ohashi (T)

Department of Physical Medicine and Rehabilitation, Shizuoka General Hospital, 4-27-1 Kita Ando Aoi-ku, Shizuoka City, 420-8527, Japan.

Midori Kitagawa (M)

Division of Rehabilitation Medicine, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Noriko Mitsuhashi (N)

Division of Rehabilitation Medicine, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Takeshi Ishi (T)

Division of Rehabilitation Medicine, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Hiroshi Fuseya (H)

Division of Rehabilitation Medicine, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Takashi Aoyama (T)

Division of Nutrition, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Akifumi Notsu (A)

Clinical Research Center, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Keita Mori (K)

Clinical Research Center, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Nobuaki Mamesaya (N)

Division of Thoracic Oncology, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Takahisa Kawamura (T)

Division of Thoracic Oncology, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Haruki Kobayashi (H)

Division of Thoracic Oncology, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Shota Omori (S)

Division of Thoracic Oncology, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Kazushige Wakuda (K)

Division of Thoracic Oncology, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Akira Ono (A)

Division of Thoracic Oncology, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Hirotsugu Kenmotsu (H)

Division of Thoracic Oncology, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Haruyasu Murakami (H)

Division of Thoracic Oncology, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Akira Tanuma (A)

Department of Rehabilitation Medicine, Juntendo Shizuoka Hospital, Juntendo University School of Medicine, 1129 Nagaoka, Izunokuni-shi, Shizuoka, 410-2295, Japan.

Toshiaki Takahashi (T)

Division of Thoracic Oncology, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH